Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.
about
Nebuliser systems for drug delivery in cystic fibrosisColistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapyEvaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis.Ethical aspects of using radiolabelling in aerosol research.Lymphangioleiomyomatosis: a case-control study of perinatal and early life events.Eradication of early Pseudomonas infection in cystic fibrosis.Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.Controlled inhalation of aerosolised therapeutics.Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study.Adaptive Aerosol Delivery (AAD) technology.Prevention of chronic Pseudomonas aeruginosa infection in people with cystic fibrosis.Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.
P2860
Q24197879-07133599-8899-4EF6-A4B6-FE055E073A1EQ27014993-6E0D87C2-3EFD-44FD-A07D-465387E9B0DBQ35049707-0DBEAAB0-A9A7-4021-B2C9-E1D85C7057F0Q35183086-7843F1F2-CC40-43F7-B832-FE871D06BB79Q35535550-76524A19-ED1B-4AFB-85B7-5FA1E9700D39Q37468065-6F7E3FEC-A46A-413A-95DA-F672CB1050ACQ37713056-CF55857E-BC93-4DAB-813C-7C3C3C998AC1Q47689004-7293464A-29EF-43DA-82B4-6BA9AEE59F80Q51056286-4329F30F-EA17-4852-896B-C54207B8C8C7Q51105413-B6BD85B6-2BA6-4D83-A49A-D96A2A964CC6Q51317864-8FCACEA3-A61D-4A03-B182-A89078880F26Q52847673-C9DCF1E0-5B35-4B84-B853-A4BAF4E3EDBEQ53217740-24FE759E-FBE7-4494-935F-2564330D453F
P2860
Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Comparison of lung deposition ...... patients with cystic fibrosis.
@en
type
label
Comparison of lung deposition ...... patients with cystic fibrosis.
@en
prefLabel
Comparison of lung deposition ...... patients with cystic fibrosis.
@en
P2093
P2860
P356
P1476
Comparison of lung deposition ...... patients with cystic fibrosis.
@en
P2093
P2860
P304
P356
10.1136/ADC.88.8.715
P407
P577
2003-08-01T00:00:00Z